Prosecution Insights
Last updated: April 19, 2026

Acrigen Biosciences

1 pending office actions

Portfolio Summary

1
Total Pending OAs
1
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
19056045 COMPOSITIONS AND METHODS FOR NUCLEIC ACID MODIFICATIONS RYAN, DOUGLAS CHARLES 1635 Final Rejection Feb 18, 2025

Managing Acrigen Biosciences's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month